BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed May 5, 2021
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option(Right to buy)
2021-05-03+245,000→ 1,185,000 totalExercise: $8.61Exp: 2031-05-03→ Common Stock (245,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2023.